The ADAP Advisory Committee advises the VDH ADAP on formulary changes, as well as programmatic, clinical and educational issues. The ADAP Advisory Committee evaluates the impact of changes to statewide HIV services on medication access and uses its findings to formulate recommendations. The purpose of the meeting is for the ADAP Advisory Committee to convene, as a group, to review data on ADAP utilization and assess implications of trends and program changes, including the impact on other statewide HIV services  

Sponsored by State Board of Health
www.vdh.virginia.gov